The effects of antacids on enteric-coated salicylate preparations.
A volunteer study was undertaken in which the effect of the co-administration of therapeutic doses of aluminium hydroxide and magnesium trisilicate on the excretion of aspirin derived from enteric-coated preparations was studied. A significant alteration in the pattern of salicylate excretion was seen, but the mechanism of the interaction cannot be deduced from the present study. It was concluded that the interaction was of potential therapeutic importance, and further studies based on this pilot investigation have been initiated.
D000328:Adult; D000863:Antacids / Q000008:administration & dosage / Q000494:pharmacology*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D001241:Aspirin / Q000009:adverse effects / Q000627:therapeutic use; D004415:Dyspepsia / Q000209:etiology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012459:Salicylates / Q000008:administration & dosage / Q000494:pharmacology*; D013608:Tablets, Enteric-Coated; D013997:Time Factors
D000863:Antacids; D012459:Salicylates; D013608:Tablets, Enteric-Coated; D001241:Aspirin